Futura Medical (LON:FUM) Trading Down 3.3% – Time to Sell?

Futura Medical plc (LON:FUM)’s stock price traded down 3.3% on Wednesday . The stock traded as low as GBX 1.11 and last traded at GBX 1.19. 2,425,055 shares were traded during trading, a decline of 59% from the average session volume of 5,952,929 shares. The stock had previously closed at GBX 1.23.

Futura Medical Price Performance

The firm’s fifty day moving average is GBX 1.20 and its two-hundred day moving average is GBX 1.55. The firm has a market capitalization of £6.92 million, a PE ratio of -0.57 and a beta of 0.21.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.